A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
This research study is investigating a new medication called nipocalimab for adults who have moderate to severe Systemic Lupus Erythematosus (SLE), often just called lupus. Lupus is a long-term condition where your immune system mistakenly attacks healthy parts of your body, causing inflammation and redness in various organs. The main goal of this study is to find out how effective nipocalimab is compared to a placebo (a treatment with no active medicine) in managing lupus symptoms and disease activity. Participants will also continue their standard lupus treatments. It's a Phase 3 study, meaning it's a later stage of research that tests the treatment in a larger group of people to confirm its effectiveness and monitor for side effects.
Auf einen Blick
Worum geht es in dieser Studie?
This study is investigating a new treatment called nipocalimab for a condition known as Systemic Lupus Erythematosus, or lupus. Lupus is an autoimmune disease, which means your body's immune system, which normally fights off infections, starts attacking your own healthy tissues instead. This can lead to swelling, pain, and damage in various parts of the body, including joints, skin, kidneys, and other organs.
The main purpose of this study is to see if nipocalimab can help people with moderate to severe lupus. Researchers want to compare its effects against a placebo, which is a treatment that looks identical but contains no active medicine. This comparison helps them understand if any improvements seen are due to the new medicine or other factors. All participants will also continue to receive their usual lupus care.
By taking part, you would be helping doctors and scientists better understand lupus and potentially find new ways to manage it. This kind of research is crucial for developing better treatments for chronic conditions like lupus, aiming to improve the quality of life for those affected.
Wichtige Erkenntnisse
- New medicine (nipocalimab) for moderate to severe lupus being tested.
- Compares nipocalimab against a dummy treatment (placebo).
- Participants continue their usual lupus care.
- For adults aged 18-75 with an existing lupus diagnosis.
- Involves regular clinic visits for health checks and monitoring.
Wer könnte berechtigt sein?
To join this study, you would need to be an adult between 18 and 75 years old and have a confirmed diagnosis of lupus for at least 24 weeks (about six months) before the study starts. Your lupus symptoms need to be currently active and considered moderate to severe by the study doctors. You should also be generally stable and healthy otherwise, based on a medical check-up, medical history, and heart test (ECG).
There are also certain conditions that would prevent you from taking part. For example, if you have severe, uncontrolled, or rapidly worsening problems with your liver, kidneys, heart, or other major organs, or other serious health issues. You also couldn't join if you have a known problem with your immune system not related to lupus, or a history of severe allergic reactions to medicines similar to nipocalimab or its ingredients. If your lupus is currently unstable and likely needs immediate changes to your usual treatment, you wouldn't be able to participate either.
Könnte diese Studie für Sie geeignet sein?
Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.
- Sind Sie zwischen 18 und 75 Jahre alt?
- Have you been diagnosed with lupus for at least 6 months?
- Do you currently have moderate to severe lupus symptoms?
- Are you generally stable and healthy, aside from your lupus?
- Do you NOT have a severe, uncontrolled health problem affecting your liver, heart, or other major organs?
Was beinhaltet die Teilnahme?
If you decide to take part in this study, you would receive either the study medicine (nipocalimab) or a placebo, in addition to your current lupus treatments. You would have regular visits to the clinic for medical examinations, blood tests, and to discuss how you're feeling. These visits help the study team monitor your health, how your lupus is responding, and check for any side effects.
The total duration of your participation in the study is not specified in detail here, but these types of studies typically involve multiple study visits over several months to over a year. You would be given a detailed schedule of visits and what to expect at each appointment before you agree to join. All study medicines and care directly related to the research will be provided by the study team.
Potenzielle Risiken und Vorteile
Locations (260)
- David S Hallegua MD A Professional CorporationVerifizierte PostleitzahlBeverly Hills, Vereinigte Staaten· Rekrutierung
- Providence Medizinische StiftungVerifizierte PostleitzahlFullerton, Vereinigte Staaten· Rekrutierung
- Southland Arthritis and Osteoporosis Medical Center Inc dba Southland ArthritisVerifizierte PostleitzahlHemet, United States· Rekrutierung
- Advanced Medical ResearchVerifizierte PostleitzahlLa Palma, United States· Rekrutierung
- Medvin Clinical Research San LeandroVerifizierte PostleitzahlSan Leandro, United States· Rekrutierung
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterVerifizierte PostleitzahlTorrance, Vereinigte Staaten· Rekrutierung
- Solace Clinical Research CaliforniaVerifizierte PostleitzahlTustin, Vereinigte Staaten· Rekrutierung
- Inland Rheumatology Clinical Trials Inc.Verifizierte PostleitzahlUpland, United States· Rekrutierung
- Denver Arthritis ClinicVerifizierte PostleitzahlDenver, Vereinigte Staaten· Rekrutierung
- Arthritis & Rheumatic Disease SpecialtiesVerifizierte PostleitzahlAventura, United States· Rekrutierung
- Clinical Research of West Florida 1Verifizierte PostleitzahlClearwater, United States· Rekrutierung
- Avanti Clinical Research CorpVerifizierte PostleitzahlHialeah, Vereinigte Staaten· Rekrutierung
Häufige Fragen
What is lupus (Systemic Lupus Erythematosus)?
Lupus is a long-term condition where your immune system mistakenly attacks healthy parts of your own body, causing inflammation and damage to various organs and tissues.
What is nipocalimab?
Nipocalimab is an experimental medicine being tested in this study to see if it can help manage moderate to severe lupus symptoms.
Was ist ein Placebo?
A placebo is a treatment that looks exactly like the study medicine but doesn't contain any active drug. It helps researchers compare the effects of the active medicine.
Will I still take my regular lupus medicines?
Yes, participants in this study will continue to receive their standard lupus treatments alongside either nipocalimab or the placebo.
Kann ich die Studie verlassen, wenn ich meine Meinung ändere?
Yes, you are free to withdraw from the study at any time, for any reason, and this will not affect your usual medical care.
Wie Sie mehr erfahren können
Studienkontakt
Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.
Interessiert daran, teilzunehmen?
Diskussion
Community-Diskussion
Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.